Spots Global Cancer Trial Database for systemic chemotherapy
Every month we try and update this database with for systemic chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC | NCT04682249 | ICC | Systemic Chemot... Sintilimab Apatinib | 18 Years - 75 Years | Sun Yat-sen University | |
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | NCT04553458 | Hepatocellular ... | Radiofrequency ... Trance-arterial... Liver resection Combined radiof... Percutaneous et... Systemic chemot... Sorafenib Viscum Symptomatic tre... | 18 Years - | Sohag University | |
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis | NCT02420509 | Cancer | systemic chemot... | 18 Years - | University of California, San Diego | |
HAIC Versus Systemic Chemotherapy for Unresectable ICC | NCT03771846 | Intrahepatic Ch... | irinotecan, oxa... gemcitabine and... | 18 Years - 75 Years | Sun Yat-sen University | |
Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT01086618 | Colorectal Canc... | systemic chemot... adjuvant therap... quality-of-life... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer | NCT03349827 | Peritoneal Meta... | exploratory lap... HIPEC Systemic chemot... Apatinib | 18 Years - 75 Years | Wuhan University | |
Second Look Laparoscopy in Colorectal Cancer | NCT01628211 | Colorectal Canc... | Laparoscopy peritonectomy Folinic Acid 5-Fluorouracil Oxaliplatin systemic chemot... | 18 Years - 65 Years | National Cancer Institute, Naples | |
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | NCT00076609 | Hepatocellular ... Liver Cancer | PHY906 capecitabine | 18 Years - 80 Years | PhytoCeutica | |
HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer | NCT03398512 | Peritoneal Meta... | exploratory lap... HIPEC Systemic chemot... | 18 Years - 75 Years | Wuhan University | |
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma | NCT02773485 | Cholangiocarcin... | High Dose Radia... Systemic chemot... | 18 Years - | Tata Memorial Hospital | |
Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT03636893 | Gastric Cancer Chemotherapy Ef... | FLOT Chemothera... SOX Chemotherap... | 18 Years - 80 Years | Ruijin Hospital | |
Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC | NCT04682249 | ICC | Systemic Chemot... Sintilimab Apatinib | 18 Years - 75 Years | Sun Yat-sen University | |
Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma | NCT05449366 | Peritoneal Mali... | Intraperitoneal... | 18 Years - | Erasmus Medical Center | |
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | NCT00960427 | Colorectal Canc... | systemic chemot... RNA analysis gene expression... reverse transcr... immunohistochem... laboratory biom... endoscopic biop... neoadjuvant the... sigmoidoscopy radiation thera... | 18 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer | NCT00881361 | Breast Cancer | systemic chemot... axillary lymph ... neoadjuvant the... sentinel lymph ... therapeutic con... ultrasound imag... | 18 Years - | Alliance for Clinical Trials in Oncology | |
MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer | NCT00978770 | Breast Cancer | systemic chemot... diffusion-weigh... dynamic contras... magnetic resona... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | NCT01524094 | Colorectal Peri... | Systemic chemot... Cytoreductive s... | 18 Years - 80 Years | Uppsala University | |
Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors | NCT00875004 | Anemia Unspecified Adu... | epoetin beta systemic chemot... quality-of-life... | 18 Years - 120 Years | Institut du Cancer de Montpellier - Val d'Aurelle | |
Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | NCT01031953 | Breakthrough Na... Unspecified Adu... | fosaprepitant d... systemic chemot... survey administ... quality-of-life... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis | NCT04769908 | ICC | Systemic Chemot... Lenvatinib Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer | NCT00881361 | Breast Cancer | systemic chemot... axillary lymph ... neoadjuvant the... sentinel lymph ... therapeutic con... ultrasound imag... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer | NCT01272037 | Breast Ductal C... Invasive Breast... Multicentric Br... Multifocal Brea... Synchronous Bil... | Anastrozole Exemestane Laboratory Biom... Letrozole Quality-of-Life... Systemic Chemot... Tamoxifen Citra... | 18 Years - | National Cancer Institute (NCI) | |
HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | NCT04961970 | Intrahepatic Ch... | oxaliplatin , f... gemcitabine and... | 18 Years - 75 Years | Sun Yat-sen University | |
Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma | NCT01375972 | Metastatic Bili... | S-1 plus cispla... Gemcitabine plu... | 18 Years - | Asan Medical Center | |
Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer | NCT03822130 | Successful Conv... Unresectable Ga... | Arterial cathet... Sodium Bicarbon... Systemic Chemot... Oral Chemothera... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma | NCT02584556 | Hepatocellular ... | systemic chemot... Transcatheter A... | 18 Years - 75 Years | Guangxi Medical University | |
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | NCT04553458 | Hepatocellular ... | Radiofrequency ... Trance-arterial... Liver resection Combined radiof... Percutaneous et... Systemic chemot... Sorafenib Viscum Symptomatic tre... | 18 Years - | Sohag University | |
A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis | NCT01978249 | Colorectal Canc... | Systemic chemot... primary tumor r... | 20 Years - 90 Years | Yonsei University | |
A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis | NCT01978249 | Colorectal Canc... | Systemic chemot... primary tumor r... | 20 Years - 90 Years | Yonsei University | |
Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis | NCT04370925 | Colorectal Canc... | Radical colecto... HIPEC Systemic chemot... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University |